Research
MPCC

 

This platform, located at the IRCM, offers so far two preclinical models for the colorectal cancers:

 

     - A model with hepatic metastasis by injection of cells into the spleen, followed by a splenectomy to prevent primary tumor growth.
     - An orthotopic model with injection of cells directly into the caecum. This graft will result in primary tumor growth in the caecum and the associated metastases can grow at different distant sites.

 

This platform also proposes intraperitoneal and intravenous grafts.

To complete the study, your service request can include bioluminescence imaging to follow tumor growth longitudinally. We can also perform the administration of your therapeutic drug (IP/IV/SC/PO/IM).

 

 

It could also be nice to complete your study by using our expertise to perform blood collection.

 

We plan to enlarge our offer by developing new models such as PDX « Patient Derived Xenograft » of colorectal cancers, or intrapancreatic graft.

 

Contact : MPCC@icm.unicancer.fr

 

Who can use the MPCC platform?
Any of the research laboratories in Montpellier (IRCM, IGH, IGF, INM, CRBM, IGMM and IRMB) or clinical center (ICM, CHRU) can work with MPCC.

 

If you’re interested and want to work with us, you can fill the following project application form and send it to: MPCC@icm.unicancer.fr

Project :     

 

Project application are reviewed and validated by the MPCC boards. They will examine your request and if it fits the platform objectives, they will define an order of priority.

 

Once your project application is received, we will send you an email indicating the next MPCC board meeting.

 

Price : For all price inquiries, please contact : MPCC@icm.unicancer.fr